{"text": "Oligonucleotides ( Oligos ) and 5'-32-P-Labeling", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The complementary double-stranded ( ds ) oligonucleotides ( oligos ) from the <extra_id_0> TNFalpha <extra_id_2> Protein <extra_id_1> , <extra_id_0> IL-8 <extra_id_2> Protein <extra_id_1> , <extra_id_0> IFNgamma <extra_id_2> Protein <extra_id_1> and <extra_id_0> IL-6 <extra_id_2> Protein <extra_id_1> promoters were synthesised from single stranded ( ss ) oligos ( illustrated in Table 1 ) , ( TIB Molbiol , Berlin , Germany ) and 32P-labeled with 5'gamma-P-ATP ( 3 , 000 Ci / mmol , Amersham , Braunschweig , Germany ) using the Ready-To-Go-Polynucleotide-Kinase Kit ( PNK Kit , Pharmacia LKB , Freiburg , Germany ) according to the manufacturer 's instructions .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "To test the binding specificity of the oligos , mutated oligos were used as an additional control .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Mutations in the P2 site of the <extra_id_0> IFNgamma <extra_id_2> Protein <extra_id_1> promoter [ 29 ] and in the kappa consensus sequence of the <extra_id_0> TNFalpha <extra_id_2> Protein <extra_id_1> promoter [ 55 ] have been reported to interfere with sequences , which seem to be crucial for the binding of <extra_id_0> NFAT <extra_id_2> Protein <extra_id_1> and NFkappaB proteins , respectively .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Afterwards , the ds oligos were purified via gel filtration using Probe Quant G-50 Micro Columns ( Pharmacia ) according to the manufacturer 's instructions .", "event": "<extra_id_0> <extra_id_1>"}
